Innospec Inc. Logo

Innospec Inc.

IOSP

(3.0)
Stock Price

109,71 USD

11.96% ROA

12.07% ROE

18.48x PER

Market Cap.

2.765.751.846,00 USD

4.03% DER

1.33% Yield

7.68% NPM

Innospec Inc. Stock Analysis

Innospec Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Innospec Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a minimal amount of debt (4%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Dividend Growth

The company's dividend growth has consistently increased every year in the last five years, indicating a strong track record of positive returns for investors.

4 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

5 ROE

ROE in an average range (11.73%) suggests satisfactory profitability and decent utilization of shareholders' equity.

6 PBV

The stock's PBV ratio (2.46x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

8 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (2.495) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

11 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

Innospec Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Innospec Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Innospec Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Innospec Inc. Revenue
Year Revenue Growth
1998 465.000.000
1999 516.800.000 10.02%
2000 422.400.000 -22.35%
2001 420.900.000 -0.36%
2002 451.500.000 6.78%
2003 462.200.000 2.32%
2004 480.500.000 3.81%
2005 527.700.000 8.94%
2006 532.100.000 0.83%
2007 602.400.000 11.67%
2008 640.500.000 5.95%
2009 598.500.000 -7.02%
2010 683.200.000 12.4%
2011 774.400.000 11.78%
2012 776.400.000 0.26%
2013 818.800.000 5.18%
2014 960.900.000 14.79%
2015 1.012.300.000 5.08%
2016 883.400.000 -14.59%
2017 1.306.800.000 32.4%
2018 1.476.900.000 11.52%
2019 1.513.300.000 2.41%
2020 1.193.100.000 -26.84%
2021 1.483.400.000 19.57%
2022 1.963.700.000 24.46%
2023 1.856.400.000 -5.78%
2023 1.948.800.000 4.74%
2024 1.740.000.000 -12%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Innospec Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1998 3.100.000
1999 3.900.000 20.51%
2000 3.100.000 -25.81%
2001 5.100.000 39.22%
2002 6.000.000 15%
2003 5.100.000 -17.65%
2004 10.500.000 51.43%
2005 11.200.000 6.25%
2006 11.100.000 -0.9%
2007 13.600.000 18.38%
2008 14.800.000 8.11%
2009 16.400.000 9.76%
2010 17.600.000 6.82%
2011 18.300.000 3.83%
2012 19.600.000 6.63%
2013 21.200.000 7.55%
2014 22.200.000 4.5%
2015 25.300.000 12.25%
2016 25.400.000 0.39%
2017 31.400.000 19.11%
2018 33.400.000 5.99%
2019 35.400.000 5.65%
2020 30.900.000 -14.56%
2021 37.400.000 17.38%
2022 38.700.000 3.36%
2023 46.400.000 16.59%
2023 41.700.000 -11.27%
2024 48.800.000 14.55%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Innospec Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1998 0
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 287.200.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Innospec Inc. EBITDA
Year EBITDA Growth
1998 192.400.000
1999 148.600.000 -29.48%
2000 137.500.000 -8.07%
2001 310.030.000 55.65%
2002 176.200.000 -75.95%
2003 158.500.000 -11.17%
2004 130.400.000 -21.55%
2005 140.600.000 7.25%
2006 89.000.000 -57.98%
2007 90.400.000 1.55%
2008 97.500.000 7.28%
2009 44.100.000 -121.09%
2010 98.500.000 55.23%
2011 66.600.000 -47.9%
2012 109.800.000 39.34%
2013 117.000.000 6.15%
2014 141.500.000 17.31%
2015 149.200.000 5.16%
2016 136.400.000 -9.38%
2017 189.400.000 27.98%
2018 195.200.000 2.97%
2019 202.800.000 3.75%
2020 128.600.000 -57.7%
2021 176.800.000 27.26%
2022 225.800.000 21.7%
2023 207.200.000 -8.98%
2023 212.100.000 2.31%
2024 209.600.000 -1.19%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Innospec Inc. Gross Profit
Year Gross Profit Growth
1998 237.800.000
1999 206.900.000 -14.93%
2000 183.500.000 -12.75%
2001 180.700.000 -1.55%
2002 194.200.000 6.95%
2003 204.500.000 5.04%
2004 209.500.000 2.39%
2005 189.500.000 -10.55%
2006 186.700.000 -1.5%
2007 197.400.000 5.42%
2008 186.400.000 -5.9%
2009 189.300.000 1.53%
2010 217.200.000 12.85%
2011 226.400.000 4.06%
2012 236.400.000 4.23%
2013 255.200.000 7.37%
2014 302.000.000 15.5%
2015 346.000.000 12.72%
2016 332.300.000 -4.12%
2017 403.300.000 17.6%
2018 435.000.000 7.29%
2019 466.200.000 6.69%
2020 342.700.000 -36.04%
2021 434.900.000 21.2%
2022 586.700.000 25.87%
2023 548.800.000 -6.91%
2023 582.800.000 5.83%
2024 507.600.000 -14.81%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Innospec Inc. Net Profit
Year Net Profit Growth
1998 70.400.000
1999 42.600.000 -65.26%
2000 18.300.000 -132.79%
2001 5.600.000 -226.79%
2002 52.100.000 89.25%
2003 51.800.000 -0.58%
2004 6.200.000 -735.48%
2005 -123.700.000 105.01%
2006 11.400.000 1185.09%
2007 29.500.000 61.36%
2008 12.500.000 -136%
2009 6.400.000 -95.31%
2010 73.700.000 91.32%
2011 48.900.000 -50.72%
2012 68.300.000 28.4%
2013 77.800.000 12.21%
2014 84.100.000 7.49%
2015 119.500.000 29.62%
2016 81.300.000 -46.99%
2017 61.800.000 -31.55%
2018 85.000.000 27.29%
2019 112.200.000 24.24%
2020 28.700.000 -290.94%
2021 93.100.000 69.17%
2022 133.000.000 30%
2023 156.800.000 15.18%
2023 139.100.000 -12.72%
2024 124.800.000 -11.46%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Innospec Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1998 2
1999 2 -100%
2000 1 0%
2001 0 0%
2002 2 100%
2003 2 0%
2004 0 0%
2005 -5 100%
2006 0 0%
2007 1 100%
2008 1 0%
2009 0 0%
2010 3 100%
2011 2 -50%
2012 3 0%
2013 3 33.33%
2014 3 0%
2015 5 25%
2016 3 -33.33%
2017 3 -50%
2018 3 33.33%
2019 5 25%
2020 1 -300%
2021 4 66.67%
2022 5 40%
2023 6 16.67%
2023 6 -20%
2024 5 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Innospec Inc. Free Cashflow
Year Free Cashflow Growth
1998 188.400.000
1999 100.300.000 -87.84%
2000 127.400.000 21.27%
2001 81.600.000 -56.13%
2002 88.600.000 7.9%
2003 77.400.000 -14.47%
2004 52.800.000 -46.59%
2005 35.500.000 -48.73%
2006 28.800.000 -23.26%
2007 7.300.000 -294.52%
2008 5.300.000 -37.74%
2009 80.200.000 93.39%
2010 49.400.000 -62.35%
2011 24.600.000 -100.81%
2012 44.000.000 44.09%
2013 40.800.000 -7.84%
2014 84.400.000 51.66%
2015 91.500.000 7.76%
2016 88.000.000 -3.98%
2017 50.500.000 -74.26%
2018 74.800.000 32.49%
2019 130.600.000 42.73%
2020 116.200.000 -12.39%
2021 54.100.000 -114.79%
2022 39.400.000 -37.31%
2023 128.700.000 69.39%
2023 41.400.000 -210.87%
2024 -10.900.000 479.82%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Innospec Inc. Operating Cashflow
Year Operating Cashflow Growth
1998 238.300.000
1999 108.700.000 -119.23%
2000 134.000.000 18.88%
2001 90.000.000 -48.89%
2002 100.000.000 10%
2003 85.200.000 -17.37%
2004 62.400.000 -36.54%
2005 43.800.000 -42.47%
2006 36.400.000 -20.33%
2007 47.900.000 24.01%
2008 14.400.000 -232.64%
2009 87.400.000 83.52%
2010 58.200.000 -50.17%
2011 34.700.000 -67.72%
2012 61.300.000 43.39%
2013 61.300.000 0%
2014 106.300.000 42.33%
2015 117.700.000 9.69%
2016 104.500.000 -12.63%
2017 82.700.000 -26.36%
2018 104.900.000 21.16%
2019 161.600.000 35.09%
2020 145.900.000 -10.76%
2021 93.200.000 -56.55%
2022 81.700.000 -14.08%
2023 205.900.000 60.32%
2023 58.100.000 -254.39%
2024 4.400.000 -1220.45%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Innospec Inc. Capital Expenditure
Year Capital Expenditure Growth
1998 49.900.000
1999 8.400.000 -494.05%
2000 6.600.000 -27.27%
2001 8.400.000 21.43%
2002 11.400.000 26.32%
2003 7.800.000 -46.15%
2004 9.600.000 18.75%
2005 8.300.000 -15.66%
2006 7.600.000 -9.21%
2007 40.600.000 81.28%
2008 9.100.000 -346.15%
2009 7.200.000 -26.39%
2010 8.800.000 18.18%
2011 10.100.000 12.87%
2012 17.300.000 41.62%
2013 20.500.000 15.61%
2014 21.900.000 6.39%
2015 26.200.000 16.41%
2016 16.500.000 -58.79%
2017 32.200.000 48.76%
2018 30.100.000 -6.98%
2019 31.000.000 2.9%
2020 29.700.000 -4.38%
2021 39.100.000 24.04%
2022 42.300.000 7.57%
2023 77.200.000 45.21%
2023 16.700.000 -362.28%
2024 15.300.000 -9.15%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Innospec Inc. Equity
Year Equity Growth
1998 301.100.000
1999 316.300.000 4.81%
2000 300.100.000 -5.4%
2001 296.300.000 -1.28%
2002 367.100.000 19.29%
2003 436.800.000 15.96%
2004 446.000.000 2.06%
2005 314.700.000 -41.72%
2006 225.100.000 -39.8%
2007 271.500.000 17.09%
2008 229.300.000 -18.4%
2009 157.600.000 -45.49%
2010 300.700.000 47.59%
2011 343.100.000 12.36%
2012 317.000.000 -8.23%
2013 409.400.000 22.57%
2014 515.900.000 20.64%
2015 605.600.000 14.81%
2016 654.100.000 7.41%
2017 794.700.000 17.69%
2018 826.000.000 3.79%
2019 919.300.000 10.15%
2020 945.400.000 2.76%
2021 1.033.600.000 8.53%
2022 1.042.800.000 0.88%
2023 1.149.600.000 9.29%
2023 1.130.800.000 -1.66%
2024 1.195.900.000 5.44%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Innospec Inc. Assets
Year Assets Growth
1998 806.700.000
1999 849.500.000 5.04%
2000 700.800.000 -21.22%
2001 788.700.000 11.14%
2002 747.800.000 -5.47%
2003 741.600.000 -0.84%
2004 790.600.000 6.2%
2005 675.300.000 -17.07%
2006 569.000.000 -18.68%
2007 551.100.000 -3.25%
2008 494.300.000 -11.49%
2009 543.100.000 8.99%
2010 548.300.000 0.95%
2011 568.800.000 3.6%
2012 579.400.000 1.83%
2013 794.700.000 27.09%
2014 999.900.000 20.52%
2015 1.030.000.000 2.92%
2016 1.181.400.000 12.82%
2017 1.410.200.000 16.22%
2018 1.473.400.000 4.29%
2019 1.468.800.000 -0.31%
2020 1.397.400.000 -5.11%
2021 1.570.900.000 11.04%
2022 1.603.700.000 2.05%
2023 1.707.400.000 6.07%
2023 1.618.600.000 -5.49%
2024 1.700.300.000 4.81%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Innospec Inc. Liabilities
Year Liabilities Growth
1998 505.600.000
1999 533.200.000 5.18%
2000 400.700.000 -33.07%
2001 492.400.000 18.62%
2002 380.700.000 -29.34%
2003 304.800.000 -24.9%
2004 344.600.000 11.55%
2005 360.600.000 4.44%
2006 343.900.000 -4.86%
2007 279.600.000 -23%
2008 265.000.000 -5.51%
2009 385.500.000 31.26%
2010 247.600.000 -55.69%
2011 225.700.000 -9.7%
2012 262.400.000 13.99%
2013 385.300.000 31.9%
2014 484.000.000 20.39%
2015 424.700.000 -13.96%
2016 527.600.000 19.5%
2017 615.900.000 14.34%
2018 647.900.000 4.94%
2019 549.900.000 -17.82%
2020 452.500.000 -21.52%
2021 537.900.000 15.88%
2022 563.300.000 4.51%
2023 557.800.000 -0.99%
2023 490.500.000 -13.72%
2024 504.400.000 2.76%

Innospec Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
75.95
Net Income per Share
6
Price to Earning Ratio
18.48x
Price To Sales Ratio
1.46x
POCF Ratio
12.83
PFCF Ratio
18.7
Price to Book Ratio
2.32
EV to Sales
1.36
EV Over EBITDA
11.6
EV to Operating CashFlow
11.94
EV to FreeCashFlow
17.4
Earnings Yield
0.05
FreeCashFlow Yield
0.05
Market Cap
2,77 Bil.
Enterprise Value
2,57 Bil.
Graham Number
80.35
Graham NetNet
4.72

Income Statement Metrics

Net Income per Share
6
Income Quality
1.44
ROE
0.13
Return On Assets
0.08
Return On Capital Employed
0.13
Net Income per EBT
0.76
EBT Per Ebit
1.03
Ebit per Revenue
0.1
Effective Tax Rate
0.24

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.3
Operating Profit Margin
0.1
Pretax Profit Margin
0.1
Net Profit Margin
0.08

Dividends

Dividend Yield
0.01
Dividend Yield %
1.33
Payout Ratio
0.25
Dividend Per Share
1.48

Operating Metrics

Operating Cashflow per Share
8.64
Free CashFlow per Share
5.93
Capex to Operating CashFlow
0.31
Capex to Revenue
0.04
Capex to Depreciation
1.63
Return on Invested Capital
0.11
Return on Tangible Assets
0.12
Days Sales Outstanding
57.87
Days Payables Outstanding
40.89
Days of Inventory on Hand
86.79
Receivables Turnover
6.31
Payables Turnover
8.93
Inventory Turnover
4.21
Capex per Share
2.71

Balance Sheet

Cash per Share
9,63
Book Value per Share
47,96
Tangible Book Value per Share
29.93
Shareholders Equity per Share
47.82
Interest Debt per Share
2.08
Debt to Equity
0.04
Debt to Assets
0.03
Net Debt to EBITDA
-0.87
Current Ratio
2.63
Tangible Asset Value
0,75 Bil.
Net Current Asset Value
0,37 Bil.
Invested Capital
1313400000
Working Capital
0,54 Bil.
Intangibles to Total Assets
0.26
Average Receivables
0,31 Bil.
Average Payables
0,16 Bil.
Average Inventory
308900000
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Innospec Inc. Dividends
Year Dividends Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2012 2 100%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 100%
2020 1 0%
2021 1 0%
2022 1 0%
2023 1 0%
2024 1 0%

Innospec Inc. Profile

About Innospec Inc.

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

CEO
Mr. Patrick S. Williams
Employee
2.400
Address
8310 South Valley Highway
Englewood, 80112

Innospec Inc. Executives & BODs

Innospec Inc. Executives & BODs
# Name Age
1 Mr. Ian Philip Cleminson
Executive Vice President & Chief Financial Officer
70
2 Dr. Corbin Barnes
Senior Vice President of Corporate Development & Investor Relations
70
3 Mr. Thomas C. Entwistle
President of Oilfield Services - Americas
70
4 Dr. Philip J. Boon Ph.D.
Chief Operating Officer & Executive Vice President
70
5 Mr. David Bentley Jones CPA
Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary
70
6 Dr. Ian M. McRobbie
Chief Technology Officer and Senior Vice President of Research & Technology
70
7 Mr. Trey Griffin
Senior Vice President of Human Resources
70
8 Mr. Steven W. Williams
Executive Director
70
9 Mr. Patrick S. Williams
President, Chief Executive Officer & Director
70
10 Mr. Graeme Blair
Head of Group Finance
70

Innospec Inc. Competitors